机译:血清促甲状腺素对分化型甲状腺癌风险预测的有用性不适用于微癌:1,870名中国甲状腺结节患者的结果
Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, 110001, P. R. China;
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, 110001, P. R. China;
thyrotropin; differentiated thyroid cancer; microcarcinoma; risk factor;
机译:血清促甲状腺素对分化型甲状腺癌风险预测的有用性不适用于微癌:1,870名中国甲状腺结节患者的结果
机译:高危分化型甲状腺癌患者重组人甲状腺激素或甲状腺激素撤除后放射性碘甲状腺残留消融
机译:高危分化型甲状腺癌患者重组人甲状腺激素或甲状腺激素撤除后放射性碘甲状腺残留消融
机译:放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
机译:放射性碘治疗甲状腺癌患者唾液腺功能障碍的危险因素及小鼠甲状腺的SPECT / CT成像自动化
机译:术前甲状腺素的血清浓度逐渐增加从良性甲状腺结节到乳头状甲状腺微癌然后到更大的乳头状甲状腺癌
机译:用于分化的甲状腺癌的风险预测血清甲状腺激素的有用性不适用于微癌:1,870例甲状腺结节患者的结果